Roflumilast (Daliresp) Pharmacology
Real Life Pharmacology - Pharmacology Education for Health Care Professionals - A podcast by Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist - Thursdays
Categories:
On this episode I discuss roflumilast (Daliresp) pharmacology, adverse effects, and important drug interactions. Roflumilast is indicated to reduce the incidence of COPD exacerbations. Roflumilast is significantly broken down by CYP3A4 so there are numerous drug interactions that we have to take into account. Psychiatric issues, GI upset, and weight loss are all potential adverse effects due to roflumilast.
